However, this mTOR dependent IGF-1/IGFBP5 signaling pathway has not yet been studied in the hippocampus in the context of Alzheimer’s disease and needs further investigation [41, 42, 48, 58]. The gene discussed is IGFBP5; the disease is early-onset autosomal dominant Alzheimer disease.